Literature DB >> 9616447

Opioid medication in the palliative care of motor neurone disease.

D Oliver1.   

Abstract

In the palliative care of patients with motor neurone disease (MND) symptoms are encountered that can be helped by the use of strong opioid medication. A retrospective survey of the 32 patients dying of MND at the Wisdom Hospice who required opioids showed that 75% received oral opioids, 94% received parenteral opioids and 72% received both oral and parenteral opioids. The median oral morphine dose was 60 mg/24 h, with a median duration of 51 days and the median parenteral dose was 180 mg/24 h with a median duration of use of three days. The results show that strong opioids can be used safely and effectively in the palliative care of patients with MND.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616447     DOI: 10.1191/026921698677326556

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  7 in total

Review 1.  Management of motor neurone disease.

Authors:  R S Howard; R W Orrell
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

Review 2.  Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials.

Authors:  Paul H Gordon
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

Review 3.  Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.

Authors:  Paul H Gordon
Journal:  CNS Drugs       Date:  2011-01       Impact factor: 5.749

Review 4.  Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.

Authors:  Johannes Brettschneider; Jerome Kurent; Albert Ludolph
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

5.  Pain in amyotrophic lateral sclerosis: a narrative review.

Authors:  Soyoung Kwak
Journal:  J Yeungnam Med Sci       Date:  2022-06-08

Review 6.  Palliative care for patients with motor neurone disease: current challenges.

Authors:  David J Oliver
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-05-26

Review 7.  Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis.

Authors:  Johannes Dorst; Albert C Ludolph; Annemarie Huebers
Journal:  Ther Adv Neurol Disord       Date:  2017-10-09       Impact factor: 6.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.